Draper Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $426K | Sell |
|
|||||
|
2024
Q1 | $521K | Sell |
|
|||||
|
2023
Q4 | $506K | Buy |
|
|||||
|
2023
Q3 | $365K | Sell |
|
|||||
|
2023
Q2 | $456K | Sell |
|
|||||
|
2023
Q1 | $377K | Sell |
|
|||||
|
2022
Q4 | $442K | Buy |
|
|||||
|
2022
Q3 | $658K | Buy |
|
|||||
|
2022
Q2 | $563K | Buy |
|
|||||
|
2022
Q1 | $515K | Buy |
|
|||||
|
2021
Q4 | $531K | Buy |
|
|||||
|
2021
Q3 | $638K | Buy |
|
|||||
|
2021
Q2 | $776K | Buy |
|
|||||
|
2021
Q1 | $450K | Buy |
|
|||||
|
2020
Q4 | $269K | Buy |
|